Articles related to HEALTHCARE ACCESS

The survey examined the methods used by payors to collect and monitor social determinants of health (SDOH), their high-priority disease states, the measures they feel are necessary to address disparities, how they believe those measures will affect how people access and use medications, and their ongoing and future efforts in this area.

In a study of parenteral cancer drug pricing at 61 NCI-designated cancer centers, median price markups on 25 commonly used drugs ranged from approximately 120% to 630% over acquisition cost. The paper’s authors recommend public policy prohibiting excessive markup on parenteral chemotherapies as a means to reduce unnecessary financial burden on patients.

Billionaire entrepreneur Mark Cuban is well-known for appearing on the television show Shark Tank and as the owner of the NBA’s Dallas Mavericks. Now, Cuban is taking on generic drug price inflation with the launch of his own pharmacy called the Mark Cuban Cost Plus Drug Company (MCCPDC), which is bypassing the PBM and lowering the cost of generic prescriptions for consumers.

Is there a link between climate change and poverty? Does hate affect the risk for chronic health conditions? Is telehealth the model for medicine’s future? Or will something much more ancient be reestablished? How will the Millennial worldview affect how medicine is practiced? This archive of top physician TED talks is worth your while.

Prescription drug prices rise each year in January and July. As we start off the new year, GoodRx Health is reporting that a total of 658 branded drugs have just had their prices increased an average of 4.9%, while 11 generic medications have seen their prices rise an average of 10.3%. That’s less than the 832 drugs that saw their price increase in January 2021. Among the biggest movers are Nucynta, paclitaxel, and Prilosec.